MDXG FY 2016 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$245M+30.8% YoY

Gross Profit

$213M86.8% margin

Operating Income

$884,0000.4% margin

Net Income

$12M4.9% margin

EPS (Diluted)

$0.00

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$19M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$193M

Total Liabilities

$60M

Stockholders' Equity

$133M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$245M	$187M	+30.8%
Gross Profit	$213M	$167M	+27.2%
Operating Income	$884,000	$24M	-96.4%
Net Income	$12M	$29M	-59.3%